OTC office would be established under House FDA reform legislation.
This article was originally published in The Tan Sheet
Executive Summary
FDA OTC OFFICE WOULD BE ESTABLISHED UNDER HOUSE FDA REFORM BILL introduced March 29 by Rep. Richard Burr (R-NC). The bill, which covers drug and biologics issues, would establish, within the Center for Drug Evaluation and Research, an office with sole responsibility for reviewing and acting upon "all applications or petitions to switch a drug from prescription to over-the-counter status" and "all other matters related to nonprescription drugs."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning